The glucose oxidase-peroxidase method for determining serum glucose, with the ammonium salt of 2,2'-azine-di -(3 -ethyl -benzothiazoline-(6)-sulfonic acid) as the chromogen, was adapted to use with the single-channel AutoAnalyzer and the SMA 12/60 (Technicon Corp.). The extended linearity (up to 500 mg/100 ml on both systems) eliminated the need for numerous dilutions in the 300 to 500 mg/100 ml range as required by other methods of analysis. Recovery of added glucose was excellent. Supranormal concentrations of uric acid and ascorbic acid interfered with recovery, but the effects of elevated bilirubin, creatinine, and urea, and of gross hemolysis were negligible. Sera of 337 patients (glucose concentrations: 50 to 454 mg/100 ml) were analyzed by this method on both instruments and by an automated o-toluidine method. By the latter procedure, the glucose concentration averaged 10 mg/100 ml higher. Sera from uremic patients, measured by the o-toluidine method, had glucose values up to 28.0 mg/100 ml higher than the values obtained by the glucose oxidase method. The glucose oxidase method of measuring serum glucose is a more accurate and precise index of "true glucose" than either the o-toluidine or the neocuproine methods.
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The glucose oxidase-peroxidase1 method for determining blood glucose was first introduced by Keston
(1), who utilized the oxygen acceptor o-tolidine as a chromogen. This method was subsequently automated by Marks (2) and Cramp (3) . Other techniques have been used to measure the hydrogen peroxide formed as a by-product of the oxidation of glucose by glucose oxidase. Phillips and Elevitch (4) used a fluorometric method based on the oxidation of homovanillic acid. Ware and Marbach (5) incorporated the 1Glucose oxidase is -n.glucose:oxygen oxidoreductase, EC oxidation of iodide to iodine in the presence of the molybdate ion. Trinder (6) used DL-eplnephrine as an oxygen acceptor, and Tammes and Nordschaw (7) titrated the hydrogen peroxide with a titaniumxylenol orange chelate. The most popular chromogen to date has been o-dianisidine (8) (9) (10) (11) (12) (13) (14) When stored at 4#{176}C, the reagent is stable for 4 to 6 weeks. Adaptation to the single-channel AutoAnalyzer (Figure 1 ) was effected by use of a 50 1:2 cam and 0.015 sample line. The serum sample was diluted with saline containing, per liter, 0.5 ml of "Brij" (30% by wt) and dialyzed against the GOD-Perid. reagent.
This reaction mixture was further diluted with saline before it entered a double-mixing coil and 37#{176}C heating bath. The blue chromogen was read at 599 nm in a 15-mm tubular flow cell.
The SMA 12/60 flow diagram ( Figure 2 ) illustrates how the dialyzer and 37#{176}C heating block of the neocuproine method and interference filter of 600 nm were incorporated. were not greater than ±0.05 mg/i#{174} ml. The 300.0 and 400.0 mg/i#{174} ml standards varied by ±0.02 mg/i#{174} ml, and the 500.0 mg/i#{174} ml standard by ±0.05 mg/i#{174}ml. The zero-order correlation coefficient was 0.999. Figure 4 illustrates a typical standard curve. The percent interaction on the single-channel AutoAnalyzer of the aqueous standards as well as serum specimens was 2.5% or less. The percent interaction on the SMA i2/60 was negligible and the steady state was 99 to i#{174}%. Linearity was excellent.
Each rack of specimens analyzed on the single- channel AutoAnalyzer for day-to-day precision studies was accompanied by a new set of aqueous standards. The SMA 12/60 was standardized as specified earlier. Serum glucose concentrations ranged from 87.0 to 478.0 mg/i#{174} ml. Table 1 presents a statistical summary of the data from single samples analyzed over a six-day period. Recoveries varied from 96.0 to 104.4% over the entire range of glucose concentrations.
By the o-toluidine method as the reference method, the inter-run precision of the GOD-Perid. method was evaluated by analyzing pooled serum containing weighed-in amounts of NBS glucose on both the single-channel AutoAnalyzer and SMA 12/60 (n = 10). Table 2 statistically summarizes the data. No significant difference was found (P <0.05) between the mean values in the range 150.0 to 450.0 mg/i#{174} ml. Analysis of commercial control sera (n = 2) is presented in Table 3 .
Effects of elevated serum constituents. Figure 5 shows the effects of increasing uric acid concentrations on three glucose concentrations, as measured by the GOD-Perid.
method. The data indicate that interference with glucose recovery is less at higher glucose concentrations and that glucose recovery is poorer in normoglycemic sera at uric acid concentrations of 5.0 to 10.0 mg/i#{174}ml. At serum glucose concentrations of 150.0 mg/i#{174} ml, bilirubin up to 12.5 mg/i#{174} ml did not interfere with glucose recovery. However, at a glucose concentration of 90.0 mg/i#{174} ml, a bilirubin concentration of 10.5 mg/i#{174} ml decreased recovery by 5%. The interference of ascorbic acid was tested at levels ranging from 1.0 to 16.0 mg/i#{174} ml at two glucose concentrations.
The results (Table 4) and o-toluidine methods were compared. These sera were grouped as follows: those having normal uric acid, but elevated BUN and creatinine (n = 11); those having normal creatinine, but elevated BUN and uric acid (n = 3); and those having increased uric acid, BUN, and creatinine (n = ii). For each group, the o-toluidine method gave higher average values: 10.9, 21.3, and 28.0 mg/i#{174} ml, respectively.
These results indicate that uric acid is the major interfering substance.
Normal values for this method were established by analyzing 150 sera from fasting patients, of all ages, having normal results from the SMA 12/60. The mean and two standard deviations was 86 ± 20 mg/ 100 ml.
Discussion
The data clearly indicate that the glucose oxidase- 9, 11, 13, 16, 20, 22) . Our data further show that glucose as measured by the GOD-Perid. method is 10.0 mg/i#{174} ml lower than that measured by the o-toluidine method. Moreover, the difference in the glucose concentration is as great as 28.0 mg/i#{174} ml in uremic patients. 
